PubMed · 2024

A Synthetic ERR Agonist Alleviates Metabolic Syndrome

Billon C, Schoepke E, Avdagic A, Chatterjee A (2024). A Synthetic ERR Agonist Alleviates Metabolic Syndrome. The Journal of pharmacology and experimental therapeutics.

The Journal of pharmacology and experimental therapeutics

Source: https://pubmed.ncbi.nlm.nih.gov/37739806/

Last reviewed July 14, 2026. By the PeptIQ team.

View original source

Peptides linked in PeptIQ Wiki

SLU-PP-332 — community report

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.